The effects of a number of mutations in the E.coli cyclic AMP receptor protein (CRP) have been determined by monitoring the in vivo expression and in vitro open complex formation at two semi-synthetic promoters that are totally CRP-dependent. At one promoter the CRP-binding site is centred around 41.5 base pairs upstream from the transcription start whilst at the other promoter it is 61.5 base pairs upstream. The CRP mutation E171K reduces expression from both promoters whilst H159L renders CRP totally inactive: neither mutation stops CRP binding at either promoter. The mutations K52N and K52Q reverse the effect of H159L and 'reeducate' CRP to activate transcription. CRP carrying both H159L and K52N activates transcription from the promoter with the CRP site at -41.5 better than wild type CRP. In sharp contrast, this doubly changed CRP is totally inactive with respect to the activation of transcription from the promoter carrying the CRP site at -61.5. Our results suggest that CRP can use different contacts and/or conformations during transcription activation at promoters with different architectures.
INTRODUCTION
The E. coli cyclic AMP receptor protein (CRP, also known as CAP) is a transcription activator protein important for bacterial adaptation during growth in conditions of glucose starvation (1) . CRP is, perhaps, the best understood of all transcription activators: in response to increases in cellular cyclic AMP levels, dimeric CRP binds to 22 base pair operator sequences located at target promoters and can accelerate the initiation of transcription at these promoters (2) . Much is understood about how CRP recognises the 22 base pair target, mainly due to our knowledge of the structure of CRP from X-ray diffraction analysis (3) . In contrast, our understanding of the molecular mechanisms by which CRP promotes transcription is poor, although most of the available evidence, summarised by Ushida and Aiba (4) , suggests that CRP must contact RNA polymerase. To attempt to locate sites on CRP that are involved directly in this interaction, positive control mutations have been sought by a number of groups. These are mutations in CRP that prevent transcription activation whilst not affecting CRP binding to target sites: some of these mutations may be located at CRP side chains that make direct contact with RNA polymerase during the acceleration of transcription initiation. Here we present experiments with CRP containing the positive control mutation, E171K, previously described by Irwin and Ptashne (5) , together with a study of a second mutation, H159L, which totally destroys the transcription activation function of CRP. This second mutation was chosen after local mutagenesis of the crp gene and selection for positive control alleles (Karen Chapman, unpublished results). Starting with CRP H159L, we have searched for second site revertants which restore the ability of CRP to activate transcription, reasoning that, if the H159L mutation removed a group that contacts RNA polymerase directly, revertants may create a 'patch' on CRP that restores this interaction. We show that these second site mutations occur at residue 52, a position located on the surface of CRP but not adjacent to residue 159. We suggest that it is unlikely that the changes at position 52 directly recreate a contact destroyed by H159L.
One of the most intriguing features of CRP-dependent promoters is that, in different cases, the CRP-binding sequence is located at different positions with respect to the transcription start site (2) . We recently described a series of semi-synthetic promoters in which a CRP-binding sequence resembling the consensus was cloned at different positions upstream of the same -10 sequence, derived from the melR promoter (6) . We showed that CRP-dependent transcription was optimal when the centre of the CRP-binding sequence was located 41.5 or 61. 5 
MATERIALS AND METHODS Bacterial strains, plasmids and constructions
The host strain Ml 82 cmp lac (7) was used in these studies. Table   I lists the plasmids used throughout this work.
To clone crp, the SalI-EcoRV fragment carrying the structural gene and promoter (Fig. lA) (8, 27) . crp derivatives were also 'shuttled' on BamHI-Sall fragments between pDCRP and the low copy number plasmid, pLG339 (supplied by Ian Roberts) conferring host resistance to kanamycin (9) .
The nucleotide sequences of 4 'test' promoters used in this work are shown in Fig.2 . Each promoter was cloned on an EcoRIHindIll fragment either in the broad host range lac expression vector, pRW2 (10) , conferring resistance to tetracycline or in the cat expression vector pKK232.8 (11) , supplied by Pharmacia, conferring host resistance to ampicillin.
Ml 82 cmp transformants were grown on plates or liquid media containing 80Ag/ml ampicillin to maintain derivatives of pDCRP or pKK232.8, 35Atg/ml tetracycline to maintain derivatives of pRW2 and 25Atg/ml kanamycin for pLG339 derivatives. MacConkey medium bought from Difco, was used throughout this work and the culture medium for ,B-galactosidase assays was the fructose-containing minimal medium described by Busby and Dreyfus (12) .
Recombinant DNA methods Standard methods were used for plasmid isolation, restriction, fragment purification and cloning (13) . Oligonucleotides for site directed mutagenesis were designed to effect sequence changes at positions 159, 162 and 171 (shown in Fig.3 RNA polymerase were performed precisely as before (6) . Gel binding assays were made as described by Gaston et al. (15) . changes were introduced into crp in order to create the known positive control mutation E171K and the possible positive control mutation H159L: the location of these changes and new sequences are illustrated in Fig.3 .
RESULTS

Positive control mutations in crp
To determine the effects of the E171K and H159L substitutions in CRP, we measured transcription initiation at four 'model' promoters, illustrated in Fig.2 . These promoters were cloned on EcoRI-Hindll fragments into the broad host range lac vector pRW2 ( Fig. IC) such that lac expression was dependent on promoter activity. The promoters CCpmelR and CC+20pmelR contain synthetic CRP-binding sequences positioned 41.5 and 61.5 base pairs upstream of the melR transcription start: we previously showed that transcription from these two promoters is totally dependent on CRP, and that these positions are optimal (26) promoters CCpmelR and CC+20pmelR is totally dependent on CRP. The E171K substitution reduces expression by different amounts from the two promoters, whilst H159L totally abolishes CRP-dependent activation at both promoters. To check that the mutations did not stop binding to operator sequences, the effects of CRP E171K, H159L, or wild type CRP on expression from the pgalPJ64 promoter were determined. The different crp alleles were introduced in trans to the pgalPJ64 promoter cloned in pRW2 in Ml82crp: in each case the CRP-independent expression from this promoter was totally blocked by CRP suggesting that the two mutations in crp have little or no effect on binding to DNA. From this, it is apparent that H159L is a 'strong' positive control mutation whilst E171K has less clear-cut effects.
Second site revertants of crp H159L In order to select for mutations that restored activity to CRP H159L, the BamHI-SalI fragment carrying this allele was transferred to plasmid pLG339 to give pLG339/CRP H159L. This plasmid, encoding resistance to kanamycin, was introduced into strain M182crp carrying two compatible plasmids: the broad host range plasmid pRW21CCpmelR, containing the lac genes under the control of the CCpmelR promoter, and pKK232.8/CCpmelR containing the genes encoding resistance to chloramphenicol under the control of the same CCpmelR promoter. Since CRP H159L cannot activate transcription from the CCpmelR promoter, transformants carrying all three plasmids are Lac-and Cms: Lac+ revertant colonies were then selected from plates containing chloramphenicol. In four independent colonies we found that the mutation causing lac expression and resistance to chloramphenicol was located on the pLG339 derivative encoding CRP H159L. In these four cases, the BamHISall fragment carrying crp was transferred from the pLG339 derivative back to pDCRP. The mutation(s) were located between the SphI and HindHI sites (Fig. iB) (Fig. 7 lanes a-e) . Titrations showed that the H159L mutation had little effect on the affinity of CRP binding to DNA fragments, whilst the K52N mutation weakens binding by 3-8 fold (A.Kolb, unpublished). Further experiments (Fig. 7 lanes f-i) demonstrated that the purified CRP carrying K52N (with or without H159L) still required cAMP for binding to the target site.
Next we determined the ability of the four different preparations of CRP to promote transcription at the CCpmelR and CC+20pmelR promoters. Purified CRP and RNA polymerase were incubated with DNA fragments and open complexes were probed by DNAse I : the resulting footprints are shown in Fig.  8 . In parallel to the footprinting, 32P-labelled nucleoside triphosphates were added to aliquots of the protein-DNA mixes and single-round run-off transcripts were made. After gel electrophoresis these transcripts were quantified and the relative amounts of transcript in each case are shown in Fig. 8 under the appropriate lane.
With CCpmelR (Fig.8 lanes a-g) K52N, H159L (lane e) . Interestingly, the amount of Figure 7 . Binding of different CRP derivatives to DNA fragments. The figure shows autoradiograms of gel binding assays run to detect the binding of purified CRP to 32P-labelled fragments containing the CC CRP binding site (24) . The experiment in lanes a-e was perforned with gels and all buffers containing IOOtM cAMP. In the gel shown in lanes f-i, cAMP (200AM) was included only in the incubation buffer of samples applied to lanes g and i. Lane a shows the migration of the labelled fragment alone whilst in the other lanes the fragment (lnM) was incubated with 5OnM purified CRP prior to electrophoresis. The Fig.6 with Fig.8 ).
DISCUSSION
The changes E171K and H159L in CRP are clear examples of positive control mutations that reduce the ability of CRP to activate transcription without stopping recognition and binding to operator sites. E171K has received particular attention since it alters an acidic amino acid from helix E of the helix-turn-helix motif (5) . However, in our hands, the effects of H159L are much clearer: the E171K substitution causes different effects at different promoters whilst the H 159L change results in totally inactive (lanes a-g) or CC+20pmelR (lanes h-n) promoters were labelled on the 'upper' strand at the EcoRI site (Fig.2) and incubated with different combinations of CRP and/or RNA polymerase prior to treatment with DNAse I. The figure shows autoradiograms of gels on which the resulting fragments were analysed. The (6) . Presumably these differences are a reflection of different contacts being made and broken at promoters of different architecture. All surveys have concluded that CRP-dependent promoters can be organised in many different ways (2, 4, 6, (21) (22) (23) and it now appears that CRP must be capable of activating transcription by a variety of mechanisms. To our knowledge this is the first report of a crp allele which has a clear-cut differential effect at two wellcharacterised promoters. It remains to be seen whether further genetic analysis will allow us to define clear-cut 'patches' on the CRP molecule which are essential for stimulating activity at promoters with particular geometries.
